Serum levels of 14-3-3η were highly significant in all RA patients compared to controls (p < 0.001), and there was a significant reduction at 6 months after anti-TNF therapy in patients with early disease (p=0.004) (Table 1). Here, TNF is linked to rheumatoid arthritis.